Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

The long-term prognosis after surgical resection of malignant insulinoma (INS) is poor. Novel adjuvant therapies, specifically targeting cancer stem cells (CSCs), are warranted. Therefore, the goal of this study was to characterize and target putative INS CSCs. Using fluorescence-activated cell sort...

Full description

Saved in:
Bibliographic Details
Published in:Stem Cells Dev
Main Authors: Buishand, Floryne O., Arkesteijn, Ger J.A., Feenstra, Laurien R., Oorsprong, Claire W.D., Mestemaker, Margiet, Starke, Achim, Speel, Ernst-Jan M., Kirpensteijn, Jolle, Mol, Jan A.
Format: Artigo
Language:Inglês
Published: Mary Ann Liebert, Inc. 2016
Subjects:
Original Research Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4892226/
https://ncbi.nlm.nih.gov/pubmed/27049037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2016.0032
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items